1st LD-Writethru: COVID-19 vaccine reaches phase-2 trials in China


Source: bignewsnetwork.com bignewsnetwork.com

Key Topics in this News Article:

News Snapshot:

BEIJING, June 20 (Xinhua) -- An inactivated COVID-19 vaccine candidate developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences has entered phase-2 clinical trials in China, the Science and Technology Daily reported Saturday. The phase-2 trials, which further evaluate the immunogenicity and safety of the vaccine in humans, are conducted in the southwestern province of Yunnan. The institute started the phase-1 clinical trials in May. Nearly 200 volunteers aged between 18 and 59 received the vaccine in West China Second University Hospital in Sichuan Province. The study was randomized, double-blind and placebo-controlled. A COVID-19 vaccine...